Table 4.
Risk Factors for Hypoglycemia on SC Insulin
Characteristic | Control Group (N = 155) |
Hypoglycemia on SC (N = 50) |
OR (95% CI), P |
---|---|---|---|
Resumed same home basal dose | 24 (28.2) | 12 (28.6) | 1.02 (0.45–2.31), 0.97 |
Resumed same home regimen | 8 (8.5) | 10 (21.3) | 2.91 (1.06–7.95), 0.04 |
Total daily dose >0.5 units/kg/day | 53 (34.4) | 21 (42.9) | 1.43 (0.74–2.75), 0.28 |
Scheduled short-/rapid-acting insulin | 100 (64.5) | 30 (60.0) | 0.83 (0.43–1.59), 0.56 |
NPH versus glargine insulin | 5 (3.4) | 7 (15.2) | 5.13 (1.54–17.06), <0.01 |
Regular versus aspart insulin | 11 (10.5) | 4 (12.9) | 1.27 (0.37–4.30), 0.71 |
High-dose versus low-/medium-dose SSI | 53 (35.3) | 23 (50.0) | 1.83 (0.94–3.57), 0.08 |
Data are n (%).